Anda belum login :: 27 Nov 2024 01:06 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Granulocyte Colony-stimulating Factor Attenuates Chronic Neuroinflammation in the Brain of Amyloid Precursor Protein Transgenic Mice: an Alzheimer’s Disease Mouse Model
Oleh:
Jiang, H
;
LIU, CX
;
FENG, JB
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
The Journal of International Medical Research vol. 38 no. 04 (Jul. 2010)
,
page 1305-1312.
Topik:
granulocyte colony-stimulating factor
;
inflammation
;
alzheimer's disease
;
amyloid precursor protein
;
nicotinic acetylcholine receptor
Ketersediaan
Perpustakaan FK
Nomor Panggil:
J11.K.2010.02
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Recent evidence suggests that inflammatory mechanisms contribute significantly to the progression of Alzheimer’s disease. Granulocyte colony-stimulating factor (G-CSF) is an anti-inflammatory immunomodulator, but the mechanism of its anti-inflammatory effect is unclear. This study was designed to investigate whether G-CSF could inhibit inflammation in a mouse model of Alzheimer’s disease through an alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) pathway. Mice transgenic for the V171I mutant amyloid precursor protein (APP) were injected subcutaneously with G-CSF 50 micro-g/kg per day or phosphate-buffered saline (PBS; control group) for 7 days, and wild-type C57/BL6 mice were injected with PBS daily for 7 days. Mice were killed on days 7, 14 and 28 after treatment began. Levels of alpha7 nAChR protein were significantly increased and levels of interleukin-1beta, tumour necrosis factor-alpha and nuclear factor-kappaB (NF-kappaB) protein were significantly decreased in the brain of APP transgenic mice in response to G-CSF. Levels of alpha7 nAChR protein correlated negatively with NF-kappaB levels. It is concluded that G-CSF might attenuate inflammation by down-regulating NF-kappaB and up-regulating alpha7 nAChR in the brain of APP transgenic mice, indicating a potential new therapeutic approach to Alzheimer’s disease.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)